Duke is an innovative place to be! Explore some of our highlights from this past year
Duke & Deerfield Announce Four Points Innovation
Deerfield Management commits up to $130 million to accelerate drug discovery at Duke through a newly launched company
Positive Clinical Trials & $10.7M Investment for Polarean Paves Way for NDA
Medical Imaging Device company hoping to submit new drug application (NDA) later this year
Viela Bio Announces U.S. FDA Approval of UPLIZNA™
UPLIZNA™ is the first and only B cell depleter approved for the treatment of NMOSD in adults who are anti-aquaporin-4 antibody positive
Grid Therapeutics Announces 1st Patient in Phase 1 Study
GT103 is a therapeutic antibody derived from single B cells of cancer patients
From Campus to Commercialization: Celebrating Duke’s Novel Innovations
From drug-resistant AI to AR brain models–Duke puts its innovative spirit on display again at the 3rd Annual Invented at Duke
3D-Printing Gives Medical Teams COVID Protection
COVID-19 Engineering Response Team tackles powered, air-purifying respirator (PAPR)
NASA Climbs Aboard with Support for Robot Project
Robots that insert IVs into patients’ arms already exist, this one is designed for use by someone without clinical training
FDA clearance for hernia mesh product approved for Deep Blue
Deep Blue has been approved to start selling their hernia mech technology after receiving FDA approval
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial
PBCAR269A targets BCMA for the treatment of relapsed/refractory multiple myeloma